Anusha MD

1/3- Have you ever thought of publishing papers with people you never met?This is the power of Social media. Check out our work on Social Media & Professional Development @JCOOP_ASCO as part of #COSMO. I am blessed to work under the mentorship of @drdonsdizon @DrMarkham @mtmdphd

I am deeply honored to receive the 2026 @AACR Distinguished Patient Advocacy and Engagement Award. I am alive, literally, because of research and those who have devoted their lives to advancing it. But, this recognition is not mine alone. It reflects the work of so many advocates who push for better research, better care, and a deeper understanding of what it means to live with cancer. And it is also only possible by our extraordinary community of scientists, clinicians, organizations, and companies willing to listen, value patient input and understand that lived experience is a form of expertise. Advocacy helped me find my voice and taught me how to transform suffering into purpose. I would not be the advocate I am today without the founders of LUNGevity filling a badly needed gap, and without the many patients, advocates, clinicians, scientists, nurses, organizations, and companies I’ve had the privilege to work alongside. Over the years, I’ve been honored to collaborate with people from all over the world who are committed to making research more relevant, equitable, and humane. I continue to learn from all of them and remain grateful to be a part of the greater cancer community. Thank you to AACR for this incredibly meaningful honor. There is still much more work to do, but today and this weekend, I celebrate how far this community has come and the progress we have made. #AACR26 #CancerResearch #PatientResearchAdvocate #PatientAdvocacy #ResearchMatters #LCSM #LungCancer @EGFRResisters

I’d never cried at a conference until today. Ross, thank you for this incredible talk. You’re a wonderful human, clinician, researcher, boss, mentor, and friend. The standing ovation was more than deserved. @CUCancerCenter @IASLC #TTLC26

Congrats🎉 to IASLC CEO Karen Kelly on her recognition as one of the 100 Most Influential CEOs in #Oncology. Her leadership reflects IASLC’s commitment to advancing the fight against #lungcancer worldwide.

Karen Kelly Recognized Among The 100 Most Influential CEOs in Oncology in 2025 @IASLC oncodaily.com/community/kare… #Cancer #Medicine #Health #Oncology #OncoDaily #OncoDaily100 #IASLC

If you read one thing this week, read today's @nytimes piece by @SimarSBajaj bit.ly/49ABdvd It names a truth people with #lungcancer live with every single day. This well-written article makes it clear that stigma doesn't just hurt people emotionally; it is a life or death barrier. People delay diagnosis, care, and support because they're afraid of being judged. Lung cancer is not a morality story. And nicotine addiction isn't a bad habit or personal failure - It's a DISEASE and should be treated that way, with compassion and evidence-based care, not judgment. Thank you, @JimPantelas, for always being so open and honest. And thank you, @drCarterBawam, @hawkeyestudts, @NarjustFlorezMD, and others, for continuing to remind people of the most basic truth: no one 'earns' this disease and no one 'deserves' it! Please help change the conversation and shift the narrative from shame and blame to hope and humanity. #KilltheStigma #LCSM #WordsMatter

Setidegrasib (ASP3082), a novel KRAS G12D protein degrader, showing real momentum in PDAC 💥 Strong antitumor activity in heavily pretreated pts (2L+; ~⅔ 3L+) and early synergy with setidegrasib + mFOLFIRINOX in 1L 🚀 Manageable safety, strong compliance, and durable benefit ✨

Keep Your Family Safe This Winter! As you cuddle up by the fire, make sure your home is safe—test for radon. It’s quick, easy, and gives you peace of mind for your loved ones. Learn more and get started: epa.gov/radon

Trainees/ Early Career Faculty please consider registering for this upcoming event on “From Mentorship to Manuscript” @ASCO with a line up of fantastic speakers and panelists @RyanNipp @cspramesh @IshwariaMD @ConquerCancerFd @ASCOTECAG events.zoom.us/ev/AmDPaTOYSY9…

💫 Don't miss the deadline! @ASCO Medical #Student & #Resident Forum is a great opportunity for future oncologists to present their work, and connect with peers. Apply by 1/12 to join us to present your research at @ASCOTECAG Lounge at #ASCO26! 👉tinyurl.com/5mb36fje #MedEd

Start the year by learning about cardiotoxicity of fluoropyrimidines... There is more than just coronary vasospasm... sciencedirect.com/science/articl…

🧵There was so much progress in 2025 in lung cancer treatment—and even more to look forward to in 2026. But the work isn’t done. We still need better, less toxic, and more affordable treatments for patients. Progress must reach everyone. #lcsm #yearendreview #lungcancerresearch

Social Media & Prof Develop for Oncology Profs [3/21/22] @md_anusha @audvin @DrAttai @EK_Drake @GvanLondenMD @IshwariaMD @DocLHenry @DrMMurphy @doctormb1 @doctormb1 @RManochakian @DrSMoerdler @LoebStacy @DrSGraff @YLeyfman @mtmdphd @DrMarkham @JCOOP_ASCO ow.ly/xpeZ50Iqnsf

😎As we head into 2026, we asked #hematology #oncology KOLs a tough question: "What are the top 3 papers published in 2025 in your field that are most relevant for @trainees?" Such a fun and informative project to work on with dear friends from @ASCOTECAG! Huge thanks to everyone who contributed 🙏 #ASCO26 @OncoAlert @OncBrothers @IMG_Oncologists @OncMedEdCoP #MedEd #MedTwitter #Hematology #Oncology #ASCO25 #ASH25

@docrishabhsingh @UICOMPeoria @AOA_society @IUHemOnc Congratulations and Good luck!!

Wrapped up IM residency @UICOMPeoria — finishing 10-years journey since med school began in 2015. Grateful for mentors, memories, and being named Senior Resident of the Year +@AOA_society inductee. Next up: Heme/Onc @IUHemOnc. Let’s go!

🚨 Major congratulations! 🚨 Dr. Joseph McGuirk, Division Director of Hematologic Malignancies & Cellular Therapeutics, has been awarded the prestigious 2025 KCU Alumni Lifetime Achievement Award! A true pioneer in CAR T therapy and Malignant Hematology — well deserved! 👏🎉 #KUcancer #KCUalumni #CART @KUcancercenter @OncoAlert #MedEd #MedTwitter @Larvol @USMIRCNEWS @medicalwatchBC

Starting Now: Radioimmunotherapy and Adjuvant Trials Moderated by: @RamalingamMD @WinshipAtEmory #DAVALung

Does the time of day affect ICI efficacy? Dr. Sandip Patel @PatelOncology @UCSDHealth reviewed studies showing AM > PM outcomes for anti–PD-(L)1 in NSCLC, while noting practical limits and the need for further data. #DAVALung

As the waves 🌊 settle after #ASCO25 we @DanaFarber_GU take a deeper dive 🤿 into the most impactful data! Join @DrChoueiri @BradMcG04 @AtishChoudhury as we discuss what we learned & where we’re going next! Prostate 🔗 youtu.be/heLQLuWjlzM Bladder 🔗 youtu.be/B-_f9Ev2jpM Kidney 🔗 youtu.be/-0fv7CiYRhM

@chartnote @ASCO @KUcancercenter @Oncn @anupkasi @Abdallah81MD @NausheenAhmedMD @AYACOUB7 Thank you!

Honored to moderate the Post-@ASCO 2025 Updates at @KUcancercenter. Great discussions, impactful science, and inspiring colleagues @Oncn @anupkasi @Abdallah81MD @NausheenAhmedMD @AYACOUB7

@SuyogCancer @OncoAlert I would like to join the group. Thank you

Now we have more than 700 oncologist from all over the world . Those ( practicing oncologists and fellows) who wish to join, do connect with me . Let's break the geographical barriers and share the knowledge together 🙂. @OncoAlert